UCSF Think Tank
Collaborating to Enhance Patient Care and Research Participating institutions will share research initiatives, expertise, and perspectives to foster dialogue and…
UCSF Think Tank
Collaborating to Enhance Patient Care and Research Participating institutions will share research initiatives, expertise, and perspectives to foster dialogue and…
Alkermes’s disappointment hones melanoma niche focus
…melanoma patients. Alkermes is therefore focusing its efforts primarily on mucosal melanoma, where the group sees a fast path to…
,
,
Early Clinical Trial Shows Drug Activity to Work in Patients with Acral and Mucosal Melanoma
Results of a Phase 1/2 clinical trial showed promising data for patients with advanced acral and mucosal melanoma. The results…
,
Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
…in Patients with Resected Early-Stage Melanoma. Dermatol Ther (Heidelb). 2020;10(5):985-999. doi:10.1007/s13555-020-00404-9 What Is Melanoma Skin Cancer? American Cancer Society. https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanoma.html.…
,
,
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
…drug designation is an important milestone for the nemvaleukin alfa program and underscores nemvaleukin’s potential clinical utility in mucosal melanoma,…
,
,
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
…nemvaleukin alfa program and underscores nemvaleukin’s potential clinical utility in mucosal melanoma, a particularly aggressive form of melanoma for which…
,
,
FDA Orphan Drug Designation Granted to Melanoma Drug Alrizomadlin
…uveal melanoma, 5 with muscosal melanoma, 16 with cutaneous melanoma, and 3 with an unknown primary melanoma type. An ORR…
,
,
A Closer Look at Uveal Melanoma
…main types of ocular, or eye, melanoma. Uveal melanoma is far more common than conjunctival melanoma, yet it only represents…
Celebrating a Milestone: 20 Years of the Dallas Steps Against Melanoma Walk
By Mara Klecker On April 20th, melanoma survivors, their families, and supporters will gather in Dallas for the annual AIM…
,
May in Review: A Marathon Month of Melanoma Awareness, Education, and Community
…and Mucosal Melanoma Stepping Up for Melanoma: Walks Across the Country Our Steps Against Melanoma Walks happen year-round, but May…
,
Recent Posts
Aug. 31, 2026
Women in Melanoma: A New Chapter in Europe
Aug. 31, 2026
The Legal & Financial Side of a Diagnosis: What No One Tells You
Aug. 19, 2026
Positive Phase 3 Results for Personalized mRNA Therapy in Melanoma
Aug. 07, 2026
RP1 Approved: A Long Road to a New Option for Patients
Aug. 06, 2026